Biotech Pitch Decks: Life Sciences Examples and Evidence Guide

Reading this archive: These are historical examples, not a ranking of current companies. Embedded decks contain the presenters' claims and may show forecasts. Unsourced fundraising detail blocks have been removed; a deck's presence does not prove it secured investment.

Questions to use when reviewing these decks

Identify the evidence stage behind each technical claim. Separate research progress from clinical or commercial outcomes. Explain the next validation milestone and the resources needed to reach it.

To compare the business model with a related sector, read Open Innovation in Life Sciences: Deep Dive. For another perspective on evidence and adoption, see Life Sciences Open Innovation: Future of Healthcare.

This historical archive distinguishes biotechnology and life-sciences tools from adjacent health and materials examples. A persuasive presentation is not evidence of clinical performance. Evaluate technical claims, validation methods and the status of any approvals independently.

Reading a life-sciences pitch

Separate the scientific hypothesis, demonstrated results and remaining development work. Identify the intended user and the evidence needed before the product can be adopted. For software serving life-sciences companies, examine workflow fit and customer value rather than treating it as a therapeutic product.

Cyclica

Open Cyclica deck in a separate tab

Cyclica provides tools for the entire pre-clinical drug discovery process

‍

See more details here

‍

Fyodor Biotechnologies

Open Fyodor Biotechnologies deck in a separate tab

Fyodor Biotechnologies is a medical-device company represented in this historical deck.

‍

See more details here

‍

Qualio

Open Qualio deck in a separate tab

Qualio is a scalable quality management platform for life sciences companies. Qualio helps you monitor quality levels across all stages of the development process.

‍

See more details here

‍

Adjacent health and materials examples

ELXR and Folia Water are retained as adjacent examples; neither should be described here as a drug-development startup.

ELXR

Open Adjacent health and materials examples deck in a separate tab

ELXR is a personalized cloud sports club that aggregates all your sports data in one place, giving you actionable insights and delivering personalized experiences across your devices.

‍

See more details here

‍

Folia Water

Open Adjacent health and materials examples deck in a separate tab

Folia is a new class of high-performance fibers that can be produced at the low cost and large scale of paper mills, using conventional equipment.

‍

See more details here

‍

Theranos: a cautionary case, not a model to copy

In March 2018, the SEC charged Theranos, Elizabeth Holmes and Ramesh Balwani with fraud. The announcement described misleading claims about technology, business and financial performance. The case illustrates why fundraising success and presentation quality cannot substitute for independent technical evidence. Read the SEC announcement.

Theranos is excluded from the recommended deck examples. Intercom and Roam and Wander have also been removed from this sector roundup because their described businesses do not fit its life-sciences focus.